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Abstract Coccidiostats are the only veterinary drugs still
permitted to be used as feed additives to treat poultry for
coccidiosis. To protect consumers, maximum levels for their
presence in food and feed have been set by the European
Union (EU). To monitor these coccidiostats, a rapid and
inexpensive screening method would be a useful tool. The
development of such a screening method, using a flow
cytometry-based immunoassay, is described. The assay uses
five sets of colour-coded paramagnetic microspheres for the
detection of six selected priority coccidiostats. Different
coccidiostats, with and without carrier proteins, were
covalently coupled onto different bead sets and tested in
combination with polyclonal antisera and with a fluorescent-
labelled secondary antibody. The five optimal combinations
were selected for this multiplex and a simple-to-use sample
extraction method was applied for screening blank and spiked
eggs and feed samples. A very good correlation (r ranging
from 0.995 to 0.999) was obtained with the responses
obtained in two different flow cytometers (Luminex 100 and
FLEXMAP 3D). The sensitivities obtained were in accor-
dance with the levels set by the EU as the measured limits of
detection for narasin/salinomycin, lasalocid, diclazuril, nicar-
bazin (4,4′-dinitrocarbanilide) and monensin in eggs were
0.01, 0.1, 0.5, 53 and 0.1 μg/kg and in feed 0.1, 0.2, 0.3, 9
and 1.5 μg/kg, respectively.
Keywords Coccidiostats . Multiplex flow cytometric
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Introduction
Coccidiosis is a protozoan infection of the intestinal tract,
caused by protozoa belonging to the genus Eimeria, which
especially affects poultry. These infections result in econom-
ic losses because of decreased growth rate, reduced egg
production and increased mortality [1]. To control this dis-
ease, a range of different coccidiostats are used as feed
additives. Currently, 11 different coccidiostats are author-
ised in the European Union (EU) for the prevention of
coccidiosis in chickens, turkeys and rabbits (Regulation
(EC) No 1831/2003) [2]. These coccidiostats can be
grouped into two major types. The first group includes the
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polyether group-containing ionophores which are produced
by micro-organisms and comprises the six following sub-
stances: monensin, lasalocid, maduramicin, narasin, salino-
mycin and semduramicin. Their biological activity is based
on their ability to form lipid-soluble and dynamically re-
versible complexes with cations. The second group includes
the synthetic products not of an ionophoric nature: decoqui-
nate, robenidine, halofuginone, diclazuril and nicarbazin
(equimolar complex of 4,4′-dinitrocarbanilide (DNC) and 2-
hydro-4,6-dimethylpyrimidine (HDP)). DNC is the anticocci-
dial active substance, but this activity increases when DNC is
administered as a complex with HDP. Moreover, the excretion
of DNC by chickens is slower than for HDP and DNC was
therefore selected as a marker for residue detection [3].
These coccidiostats are not allowed to be used in egg-
laying chickens and in broilers 5 days before slaughter.
Maximum (residue) levels for the presence of coccidiostats
in food (maximum residue limits (MRLs); Commission
Regulation (EC) 124/2009 [4] and Commission Regulation
(EC) 1353/2007 [5]) and feed (maximum limits (MLs);
Commission Regulation No. 574/2011) [6] have been set
within the EU (Table 1), to protect animals and animal
products from the unintentional treatment induced by
carry-over rates of feed produced with the highest author-
ised dose of the coccidiostats into the afterwards produced
non-target feed. The 11 authorised coccidiostats are includ-
ed into the National Monitoring Programme (96/23/EC) [7]
and EU member states are obliged to monitor eggs and feed
samples for their presence.
To monitor these coccidiostats, two different types of
methodologies have been developed to detect one or more
coccidiostats simultaneously. Firstly chromatography-based
methods such as high-performance liquid chromatography [8,
9] and liquid chromatography-mass spectrometry (LC-MS)
[1, 10–15] and secondly immunoassays [10, 16–21] including
lateral flow devices [22] and a surface plasmon resonance-
based biosensor [23]. During the last number of years,
chromatography-based methods have improved with respect
to reduced analysis time (including sample preparation time)
and multiplexed detection. However, immunoassays still have
several advantages over physico-chemical techniques such as
their lower cost, their ease-of-use and speed. Yet to date
virtually all of these immunoassays can only detect one or
two of the coccidiostats simultaneously.
The flow cytometry-based immunoassay (FCIA) ap-
plied in the present study is an interesting suspension
array format, combining the favourable properties of an
immunoassay with the opportunity of combining assays
(multiplexing). This FCIA uses paramagnetic micro-
spheres, which are internally dyed with a red and an
infrared fluorophore. By varying the ratio of the two
fluorophores, up to 100 different colour-coded bead sets
can be distinguished and different compounds or conjugates
can be coupled on the surfaces of different bead sets.
The carboxylated bead surface allows simple chemical
coupling of capture reagents such as antibodies, oligonu-
cleotides, proteins, peptides, polysaccharides or receptors.
For the coating of the beads with proteins, standard proce-
dures are available [24]. The coating with low molecular
weight compounds is usually accomplished by conjugating
them to a carrier protein. Such procedures have been de-
scribed for the detection of pesticides [25], the thyroid
hormone thyroxine [26], veterinary drug residues [27, 28],
polycyclic aromatic hydrocarbons [29, 30], mycotoxins [31]
and explosives (TNT) [32]. The direct coupling of a low
molecular weight sulfonamide to the beads was also de-
scribed by de Keizer et al [33], and this resulted in an
improved bead stability with higher responses and an easier
coupling procedure.
Antibodies can bind to these immobilised compounds or
conjugates on the beads and these binding events will be
inhibited by the presence of free compounds in the sample
in the applied inhibition immunoassay format. The bound
antibodies are quantified by a secondary antibody (IgG)
labelled with the fluorescent protein R-phycoerythrin (PE).
Inside the dual-laser flow cytometer, one light source (red
laser) excites the internal dyes that identifies each micro-
sphere, and one (green laser) quantifies the PE reporter dye
on the surface of the bead reflected as median fluorescence
intensity (MFI). This makes it possible to simultaneously
measure up to 100 different compounds in a single well.
In the present study, a very attractive high throughput
multiplex FCIA was developed for the simultaneous detec-
tion of six priority coccidiostats (Fig. 1) in eggs and feed.
Currently, five bead sets are used for this assay but new
developed assays can be added at any time to broaden the
scope of this multiplex. The multiplex includes the four
Table 1 Maximum (residue) levels for coccidiostats in eggs (MRLs)
and feed (MLs; EU legislation) [4–6]
Eggs (μg/kg) Feed (μg/kg)
Lasalocid sodium 150 1,250
Monensin sodium 2a 1,250









a Not specified for eggs but as ML in other food of animal origin
b New ML since 2011
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polyether ionophores, salinomycin, monensin, narasin and
lasalocid, which are most commonly used in poultry
[34],[35]. The fifth compound is nicarbazin, a synthetic
complex composed of an equimolar amount of DNC and
HDP. The sixth compound included within the assay is
diclazuril, which belongs to the group of triazinones and is
active against intracellular development stages of coccidia.
During the development of the five-plex immunoassay,
the coccidiostats with and without carrier proteins, were
covalently coupled onto different types of carboxylated
beads (paramagnetic and non-paramagnetic beads) and
compared for their performances in two different flow
cytometers and in combination with new and previously
developed polyclonal antisera. The five optimal combina-
tions were selected for the multiplex development. Cross-
interactions between the assays and cross-reactivities within
the assays were examined. For the assay which detects both
narasin and salinomycin, special attention was paid to select
a combination with an equal sensitivity for both compounds.
Different assay parameters such as, concentrations of the
reagents, incubation temperatures and time and buffer com-
position were trialled. Following this optimisation phase,
blank and samples spiked egg and feed samples at relevant
concentrations, incurred egg and contaminated feed samples
were used to optimise the simplified extraction method and
to confirm that levels set by the EU could be detected.
Materials and methods
Materials
The HBS-EP buffer and an amine coupling kit (containing
0.1 M N-hydroxysuccinimide (NHS) and 0.4 M 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC)) were supplied by GE Healthcare (Uppsala, Swe-
den). Ethylenediamine (EDA), dimethyl sulfoxide
(DMSO), dimethylformamide (DMF), acetonitrile, metha-
nol, l-glutamic acid gamma-(p-nitroanilide) (GAN), sodium
carbonate (Na2CO3), sodium hydrogen carbonate
(NaHCO3), sodium dihydrogen phosphate monohydrate,
Tween-20 and sodium azide were obtained from VWR
International (Amsterdam, The Netherlands). Goat-anti-
rabbit-R-phycoerythrin conjugate (GAR-PE) was from
Fig. 1 Molecular structures of the six priority coccidiostats
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Molecular Probes (Leiden, The Netherlands) and bovine
serum albumin (BSA), bovine thyroglobulin (BTG) and
ovalbumin (OVA) from Sigma-Aldrich (Zwijndrecht, The
Netherlands). EDC, 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid and N-hydroxysulfosuccinimide sodium salt
(sulfo-NHS) were from Pierce (Rockford, IL, USA). The
carboxylated microspheres No. 012, 021, 029, 043, 059 and
070 (SeroMAP™ (non-paramagnetic) and MagPlex®
(paramagnetic) beads), in stock bead suspensions of 1.25×
107 beads mL−1 and stored at 4–6 °C, and sheath fluid were
obtained from Luminex (Austin, Texas, USA). N-succinyl-
L-alanyl-L-alanyl-L-alanine 4-nitroanilide (SAN) was from
Fluka (Gillingham, Dorset, UK). Protein A Sepharose 4 Fast
Flow from GE Healthcare (Sweden) was used for the puri-
fication of the sera.
Blank and incurred eggs and poultry feed samples were
supplied by CER (Marloie, Belgium), FERA (York, UK)
and the Nutreco company MasterLab B.V. (Boxmeer, The
Netherlands).
Instrumentation
The measurements were performed using two flow cytom-
etry platforms. The Luminex® 100 IS 2.2 system, supplied
by Applied Cytometry Systems (Dinnington, Sheffield,
South Yorkshire, UK), consisted of a Luminex 100 analyser
and a Luminex XY Platform and operated with StarStation
System control software. The FLEXMAP 3D® system, con-
trolled with xPONENT 4.0 Software Solutions, was
obtained from Luminex (Austin, Texas, USA).
All washing steps were carried out on a Bio-Plex™ Pro II
Wash Station (Bio-Rad Laboratories, Veenendaal, The Neth-
erlands) using a magnetic plate carrier or the vacuum carrier.
Plates were incubated on a Dynatech microtiter vari-shaker
(Alexandria, VI, USA). During the coupling procedures, the
paramagnetic microspheres were captured using a
DynaMag-2™ (Invitrogen Dynal, Oslo, Norway) magnetic
separator. Mixing for sample extraction was performed in a
REAX2 (Heidolph, Schwabach, Germany) overhead shaker.
All centrifuge steps were carried out in an Eppendorf 5810
R centrifuge using the A-4-62 rotor (VWR International,
Amsterdam, The Netherlands).
Methods
Preparation of immunoreagents and antisera Polyclonal
antisera were obtained from rabbits after immunisations
with the different coccidiostats conjugated to the carrier
proteins BTG, BSA or transferrin in which three different
conjugation chemistries were applied. These chemistries
were performed at the Institute of Agri-Food and Land
Use of the Queen’s University Belfast (Belfast, UK) and
were also applied for the couplings to OVA or horse-radish
peroxidase (HRP).
The N,N′-disuccinimidyl carbonate (DSC) reaction was ap-
plied for the conjugation of diclazuril, lasalocid and salino-
mycin to proteins. DSC consists of a carbonyl group
containing two NHS esters. The compound is highly reac-
tive towards nucleophiles and, in non-aqueous conditions, it
can be used to activate a hydroxyl group to a succinimidyl
carbonate derivative. DSC-activated hydroxyl compounds
can then react with amine-containing molecules to form
stable cross-linked products. For the activation, the drug was
mixed with a six times molar excesses of DSC and dimethy-
laminopyridine, all dissolved in dry acetone. After mixing for
3–4 h at room temperature (RT), the acetone was evaporated
to dryness under a stream of nitrogen and the activated drug
was re-suspended in PBS (pH 7.5). DMSO or pyridine was
used if the product was insoluble in water. The activated drug
was added in a molar ratio equivalent to the number of amines
groups to the protein (50 mg) dissolved in PBS and incubated
for at least 4 h at RT or overnight (ON) at 4 °C.
The N,N′-carbonyldiimidazole (CBDI) reaction was ap-
plied for the conjugation of lasalocid, monensin, salinomy-
cin, narasin and GAN (a mimic of the active component
DNC in nicarbazin) to proteins. The activation of the car-
boxylate group with CBDI provides an intermediate imide
with imidazole as the active leaving group. In the presence
of a primary amine-containing compound, the nucleophile
attacks the electron-deficient carbonyl, displacing the imid-
azole and forming a stable amide bond. The drug dissolved
in DMF was added to a six times molar excess of CBDI
dissolved in acetone and stirred at RT for 4 h and the
acetone was then evaporated. The protein (10–20 mg/mL)
was dissolved in carbonate/bicarbonate buffer (pH 9.6), and
the activated drug was slowly added whilst stirring. The
mixture was incubated ON at 4 °C.
The carbodiimide reaction was applied for the conjuga-
tion of diclazuril and SAN (another mimic of the active
component DNC in nicarbazin). In this, EDC reacts with
carboxylic acids (hapten or protein) to form highly active O-
acetylisourea intermediates which can then react with a
primary amine to form an amide bond and release EDC as
a soluble isourea derivative. NHS can be used with EDC to
increase the stability of the active intermediate. The drug
(10 mg) was dissolved in 0.05 M 2-(N-morpholino)ethane-
sulfonic acid (MES) and 0.5 M sodium chloride (pH 4.7) or
pyridine. EDC (10 mg) and NHS (5 mg) dissolved in
0.005 M MES; 0.5 M sodium chloride (pH 4.7) were added
to the drug and mixed for 15 min. The protein (20 mg) was
dissolved in PBS and added to the activated drug dropwise
and allowed to incubate ON at RT.
All the protein-drug conjugates were purified by over-
night dialysis against 0.15 M saline over 24 h (3×4 L).
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Immunisations were performed at CER (Marloie, Bel-
gium) and at least five rabbits were injected with the same
immunogen which was received in lyophilised form and
was reconstituted to 1 mg/mL with water for injection. For
each injection, 0.2 mg of the immunogen was emulsified
with NaCl (0.9 %) and Freund’s adjuvant by mixing vigor-
ously. A complete adjuvant was used only for the first
immunisation and incomplete adjuvant for all subsequent
booster injections. The emulsified antigens were injected sub-
cutaneously at four sites on the New Zealand white-specific
pathogen-free rabbits at days 0, 14 and 28 and then every
28 days, with test bleeds taken from the marginal ear vein
10 days after immunisations. These bleeds were collected from
the third immunisation onwards. The blood was centrifuged
and collected serum was stored at −20 °C until further use.
ELISA for evaluation of sera
Two methods were used for the evaluation of the presence of
antibodies in the sera of the immunised rabbits.
In the first assay format, the microtitre plate was coated
with purified sheep anti-rabbit IgG and diluted sera as well
as HRP-drug conjugate were added and incubated ON at
4 °C. After washing, colour developed was achieved by
given a 30-min incubation of TMB/H2O2. The reaction
was stopped by the addition of H2SO4, and the colour
intensity was measured at 450 nm.
In the second assay format, the diluted sera were coated
to the microtitre plate and buffer or standard solution as well
as the HRP conjugate were added and incubated for 2 h at
37 °C. After washing, colour development was performed as
described for assay format 1.
Immobilisation of coccidiostat-protein conjugates on the
beads HRP, BSA or OVA conjugates of lasalocid, monen-
sin, salinomycin, narasin, diclazuril and GAN were coupled
to MagPlex® paramagnetic carboxylated beads, and each to
a unique bead set, according to a standard Luminex protocol
for protein coupling [24]. The concentrated bead suspension
(1.25×107 beads/mL) was vortexed vigorously for 5 min
and then placed in an ultrasonic bath for 1 min. For each
bead coupling, 200 μL of the concentrated beads was trans-
ferred to an Eppendorf tube and placed in the magnetic
separator. Beads were allowed to settle for 3 min and the
supernatant was aspirated. The beads were washed by 500 μL
MQ water added, mixed for 1 min by vortex, placed in an
ultrasonic bath for 1 min and in the magnetic separator for
3 min and aspirating the supernatant. This was the standard
washing procedure for the paramagnetic beads. The beads
were subsequently washed with 500 μL of 0.1 M NaH2PO4
(pH 6.3), activated for conjugate coupling in 100 μL of 0.1 M
NaH2PO4 (pH 6.3) containing 500 μg of EDC and 500 μg of
NHS and incubated for 20 min at room temperature. After
activation, the beads were captured and washed once with
500 μL PBS (5.4 mM sodium phosphate, 1.3 mM potassium
phosphate and 150 mM sodium chloride; pH 7.4). Final
conjugate concentrations were adjusted to 125 μg/mL in
PBS. The activated beads were then resuspended in 0.5 mL
of the conjugate solution. Subsequently, they were incubated
for 2 h at RT in the dark with gentle agitation. After the
coupling, the conjugate solutions were removed and the beads
were washed four times with blocking buffer (PBS buffer
containing 0.1 % BSA, 0.02 % tween 20 and 0.02 % of
sodium azide). The beads were then resuspended in 200 μL
blocking buffer and stored ON at 4 °C before use.
Direct immobilisation of coccidiostats or mimics on the
beads Lasalocid, monensin, salinomycin and GAN were di-
rectly coupled to paramagnetic (MagPlex®) or non-
paramagnetic beads (SeroMAP™), and each to a unique bead
set, using a previously described procedure [33] in which the
carboxyl groups were activated by EDC/NHS. For each cou-
pling, 0.5 g of coccidiostat was dissolved in 160 μL DMSO or
DMF and the volume adjusted to 800 μL with carbonate
buffer (15 mM Na2CO3 and 35 mM NaHCO3 at pH 9.6). To
150μL of this solution, 150μL EDC and 150μLNHS (amine
coupling kit) were added and this mixture was incubated for
1 h in the dark before it was added to the activated beads. The
concentrated bead suspensions were pretreated as described
previously and 200 μL was transferred to an Eppendorf tube
and placed in a magnetic separator (paramagnetic beads) or
centrifuged for 3 min at 10,000×g for the non-paramagnetic
beads. The paramagnetic beads were washed as described
above. For the non-paramagnetic beads 500 μL MQ water
were added, the mixture was vortexed for 1 min, placed in an
ultrasonic bath for 1 min and finally centrifuged for 3 min at
10,000×g. This was the standard washing procedure for the
non-paramagnetic beads. The beads were subsequently
washed and activated as described previously. The activated
beads were captured magnetically or centrifuged and the
supernatant removed. The pellet was resuspended in 250 μL
of 0.1 M EDA (pH 8.5). After 15 min shaking at RT in the
dark, the beads were captured or centrifuged and the superna-
tant was discarded. The pellet was washed twice with 500 μL
PBS. Finally, the beads were re-suspended in the 450 μL of
activated coccidiostat solution. The mixture was incubated for
2 h in the dark in a test tube rotator, centrifuged and the
supernatant was removed. After the coupling, the drug solu-
tions were removed and the beads were washed and resus-
pended in blocking buffer as described above.
Extraction procedure for feed and eggs
Homogenised whole eggs or grinded feed (2 g) were mixed
with 8 mL of acetonitrile by immediately vortexing for 30 s.
The sample was vigorously shaken on an overhead shaker
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for 10 min and centrifuged at 2,400×g for 10 min. Of the
supernatant, 4 mL were transferred to another tube and
evaporated to dryness under a flow of nitrogen at 50 °C.
After the addition of 0.2 mL of methanol, the sample was
vortexed for 10 s. Subsequently, 0.8 mL of HBS-EP buffer
was added, the sample was vortexed for 10 s and vigorously
shaken for 10 min, followed by a centrifugation at 2,400×g
for 10 min.
Flow cytometric immunoassay protocol
Paramagnetic beads Calibration curves of the individual
coccidiostats (narasin, salinomycin, lasalocid, diclazuril,
nicarbazin (DNC) and monensin) or of a mixture of cocci-
diostats were prepared in HBS-EP buffer containing 10 %
methanol. Bead suspensions, with concentrations of around
100 beads μL−1 bead set−1, and antibody dilutions (individ-
ual or as mixture) were made in 0.1 % BSA blocking buffer
[24]. Subsequently, 10 μL of this bead suspension, 50 μL
sample extract, plus 50 μL HBS-EP buffer containing 10 %
methanol (or 50 μL blank sample extract plus 50 μL cali-
bration standard solution) and 10 μL of antibody solution
were added to a well of the flat-bottom 96-well plate and
was incubated on the microplate shaker in the dark for 1 h.
After washing three times with PBS in the Bio-Plex washer,
70 μL of 600 times diluted GAR-PE was added followed by
an incubation on the microplate shaker in the dark for
30 min. The beads were analysed with a Luminex analyser
in which about 100 beads per bead set were counted. The
antibody-binding was quantified by the response (MFI)
obtained from the amount of reporter molecule (PE) and
the amount of cocciostats in the samples were quantified by
the individual calibration curves prepared using GraphPad
Prism software, paramagnetic beads
Non-paramagnetic beads A very similar protocol to that
applied for the paramagnetic beads was used, except that
96-well filter-bottom plates were utilised which were pre-
wetted with 100 μL of 0.1 % BSA in HBS-EP and
aspirated before use. A second difference was the washing
step where the plate was only washed twice, using the




For each of the five different coccidiostat assays, antisera
from between 5 to 15 rabbits were available for testing and
for most assays with different coated beads.
Salinomycin and narasin have almost identical chemical
structures (Fig. 1) as well as identical MRLs in eggs and MLs
feed (Table 1). The aimwas therefore to develop an assay with
similar sensitivity for both coccidiostats. Of all the antisera
from the rabbits immunised with salinomycin-BTG (n05) and
narasin-BTG (n05), none showed colour development in the
ELISA. FCIAs could be made with four of these antisera
when beads were coated with their respective conjugates.
However, low cross-reactivities were observed with the two
structures. The best combination was anti-salinomycin (CF6)
combined with narasin-BSA-coated beads, which resulted in a
reasonable response (4,000 MFI) and antibody dilution
(1:400), showing a 150 % cross-reactivity for narasin com-
pared with salinomycin with a high sensitivity (IC50 for nar-
asin and salinomycin at 0.3 and 0.5 ng/mL, respectively).
For the production of polyclonal sera against monensin,
two attempts with each five rabbits immunised with
monensin-BTG (CF1-CF5) or monensin-CBDI-BTG
(CF141-CF145), and one attempt with five rabbits immu-
nised with monensin-CBDI-BSA (CF146-CF150) were
done. They did not present any satisfying results in the
applied ELISAs. Likewise no (n06) or low (n09) responses
were seen with the FCIA using the direct monensin-coated
beads. When monensin-OVA-coated beads were used, high
responses were observed but with a very low sensitivity
(IC50 for monensin, >3,000 ng/mL). A new monensin-
BSA conjugate was therefore produced, coupled to the
beads and performed best with the antisera CF141-CF145
(monensin-CBDI-BTG). For further optimisation one of the
antisera (CF141) was affinity purified using a protein A
column. These modifications had a positive effect on the
sensitivity of the assay (IC50 of 0.3 ng/mL) and the maxi-
mum response obtained (4,000 MFI).
With three of the antisera of the rabbits (n05) immunised
with diclazuril-BTG, binding was observed in the ELISA and
FCIA however, the IC50 values were high (100–900 ng/mL
for the ELISA and >3,000 ng/mL for the FCIA). A previously
developed antiserum against carboxy-diclazuril-BTG (CT28)
gave a better sensitivity in the ELISA (IC50 of 5.2 ng/mL for
free diclazuril). Similar results were seen in the FCIA and the
best combination was CT28with diclazuril-HRP coated beads
(IC50 of 1.9 ng/mL).
Of the rabbits immunised with lasalocid-protein conju-
gates (n015), only a few showed low binding in the ELISA
and the FCIA of which one (CF131) showed a good sensi-
tivity (IC50 of 0.5 ng/mL) in combination with lasalocid-
OVA-coated beads.
The rabbits (CF21–CF25) immunised with SAN-BTG
showed binding in the ELISA with reasonable sensitivities
(IC50 values for DNC of 20 to 1,000 ng/mL) and two of
them (CF21 and CF22) performed well in the Luminex
with the structural mimic GAN-OVA-coated beads (IC50
of 4–9 ng/mL).
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Singleplex assay development
The goal of this research was to develop a multiplex FCIA
for the simultaneous detection of six different coccidiostats
at or below the MRLs and MLs prescribed within the EU for
eggs and feed (Table 1). Different protein conjugates were
made for the immunisations (BTG or BSA) of the rabbits
and for the coupling to the beads (HRP or OVA). Of the
three available bead types, all detectable in the two applied
flow cytometers (Luminex® 100 and the FLEXMAP 3D®),
the MicroPlex® beads were not used because of the possible
problems with non-specific binding [36]. The SeroMAP™
beads (non-paramagnetic beads) were designed for reducing
these non-specific interactions, especially in serological
assays. The MagPlex® beads are paramagnetic with the
advantage that they are easier to handle during couplings
but also during analysis in which the beads can be trapped
on the bottom of the well by a magnet during the washing
procedure. This gives the opportunity to remove unwanted
sample compounds from the well. The non-paramagnetic
beads have to be used in combination with filter plates
during the washing procedures and unwanted sample com-
pounds will stay in the well. The other differences between
the two chosen bead types were the diameters (6.5 μm for
the paramagnetic beads versus 5.6 μm for the non-
paramagnetic beads) and the surfaces of which the paramag-
netic beads are more irregular leading to a larger surface
area, an expected larger number of carboxyl groups on the
surface and higher coupling quantities. The bead-coating
with low molecular weight compounds is usually achieved
via carrier proteins. However, as shown before [33], a direct
coupling of a low molecular weight compound to the bead
could improve the stability of the coupled beads. Therefore,
three coccidiostats and one mimic (GAN), all containing a
carboxyl group, were directly coupled to the two bead types
with EDA as the spacer and their performances in the
individual FCIAs, with a selection of antisera, were com-
pared with those applying paramagnetic beads coated with
protein conjugates (Table 2). Diclazuril was not included in
this comparison due to the more complex coupling proce-
dure. However, the direct coupling onto paramagnetic beads
showed insufficient responses in all four assays, and could
not be used for further assay development. With the beads,
the direct coupling resulted in only two suitable assays
(Table 2). Overall, the assays based on protein-conjugate-
coupled paramagnetic beads showed higher responses at
higher antisera dilutions resulting in higher sensitivities
and lower IC50 values (Table 2). The used conjugates had
substantial influences on the sensitivities and the maximum
signals of the assays. This might also explain the difference
found between the results obtained with the FCIAs and
ELISAs.
Five-plex immunoassay specificity and sensitivity
of the assays
The five singleplex assays had to be combined within a
single well to create the multiplex format. Therefore, a high
specificity of the antibodies for their corresponding beads
was mandatory and cross-interactions between the assays
had to be avoided as much as possible. During the first
experiments, such cross-interactions were observed from
the monensin and lasalocid antibodies to the narasin and
nicarbazin/DNC beads. This problem was solved by using
paramagnetic beads for all assays, narasin- and monensin-
BSA conjugates and protein A-purified monensin and lasa-
locid antibodies. An unexpected advantage of this purifica-
tion was the increased assay sensitivity by a factor of 10 and
2, respectively. After these changes, the mixture of the five
bead sets was again incubated with the selected individual
antisera (Table 3) to check for cross-interactions.
As shown in Fig. 2, the antibodies reacted mainly to their
corresponding beads. The diclazuril antiserum showed low
cross-interaction with all other beads (<10 %). The salino-
mycin antiserum had a low binding with the lasalocid beads
and less with the monensin beads. The monensin antibody
now showed low cross-interactions with all other beads due
to the purification and high dilution of the antiserum. The
diclazuril bead showed the lowest interactions with the other
antibodies due to the high maximum MFI (20,000 MFI)
obtained with the anti-diclazuril. Although these interac-
tions were all below 20 %, together they had an influence
Table 2 Comparison of sensitivities (IC50 value), antibody dilutions and maximum responses (MFI), in the Luminex 100 flow cytometer, of the
singleplex assays using two different beads couplings and the optimal dilutions of the polyclonal antisera
Coccidiostat on the bead Antibody Direct coupling (non-paramagnetic beads) Protein conjugate coupling (paramagnetic beads)
IC50 (ng/mL) Antibody dilutions Max MFI IC50 (ng/mL) Antibody dilutions Max MFI
Salinomycin CF6 >5,000 80 4,500 0.3 1,200 4,000
GAN (nicarbazin mimic) CF21 4 500 5,000 9 1,000 20,000
Monensin CF141 25 200 4,000 0.3 1,000 4,000
Lasalocid CF131 – 100 300 0.5 200 2,000
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on the calibration curves as these interactions could not be
inhibited by any of the coccidiostats. As shown in Fig. 3C,
the highest inhibition was obtained with the diclazuril assay
of which the beads showed no interactions with other anti-
sera. The lowest inhibition was obtained with the lasalocid
assay of which the beads showed the most interactions with
the other antisera. The antibody-binding was quantified by
the reporter molecule (PE) and expressed in MFI which was
corrected for intra-assay and daily inter-plate fluctuations by
calculating the percentage of relative binding (B/B0) calcu-
lated from the maximum response (B0) obtained without any
analyte.
To test for cross-reactivities towards the 11 authorised
coccidiostats (Table 1), a high concentration (1,000 ng/mL)
of each coccidiostat in buffer was analysed in the five-plex
and the only significant inhibition seen (>30 %) was for
narasin in the salinomycin assay. The chemical structures of
narasin and salinomycin only differ by one methyl group
and the high cross-reactivity (150 % for narasin), obtained
by comparing dose–response curves, was expected. The
chemical similarities of the other nine authorised coccidio-
stats are low and therefore cross-reactivities were, as
expected, low (<1 %).
Nicarbazin is a synthetic complex of an equimolar
amount of DNC and HDP. The excretion of DNC by chick-
en is slower than for HDP and DNC was selected as a
marker compound for residue detection. DNC will be pres-
ent in eggs where nicarbazin has been added to laying hens
feed. This assay had to be applicable to both eggs and feed
analysis and proved to be fit for purpose in both matrices to
reliably detect DNC reflecting the initial presence of nicar-
bazin at or below the levels set in legislation.
Assay performance in sample materials
Ideally, the five-plex screening method should have a sim-
ilar extraction procedure for both egg and feed samples.
Different extraction procedures, described for MS analysis
[13, 14], were selected, simplified by performing only the
liquid–liquid extraction and tested. Different assay circum-
stances were tested and a reduction of the first incubation
step was not an option because this resulted in higher
standard deviations. Temperature adjustments had only a
small impact and RTwas selected to minimise the necessary
equipment. Different buffers, like PBS and HBS could be
used without any problem if a detergent or a 0.1 % BSA or
OVA was added. The optimal assay and extraction proce-
dures (see “Materials and methods”) were selected for sen-
sitivity, recovery, usefulness for eggs and feed, costs, easy to
use and time consumption.
Matrix influences were investigated with calibration
curves of the five mixed coccidiostats in buffer, egg and
feed extracts (Fig. 3). Substantial differences in assay per-
formance were observed in the nicarbazin (DNC) assay. The
assay sensitivity was found to be reduced 40-fold in egg
extract but only 4-fold in the feed extract. These reductions
in sensitivity were believed to be due to interfering com-
pounds present in the sample extract as the coccidiostats
were added after the extraction to generate the calibration
curves. All assays showed a loss in sensitivity when the
calibration curves were constructed in egg or feed extracts,
as opposed to buffer. It is possible that coccidiostats bind to





Antibody used Immunogen Immunogen conjugate
chemistry
Salinomycin Narasin-BSA CBDI CF6 Salinomycin-BTG DSC
Narasin Narasin-BSA CBDI CF6 Salinomycin-BTG DSC
Diclazuril Diclazuril-HRP DSC CT28 Carboxy diclazuril Carbodiimide
Monensin Monensin-BSA CBDI CF141 Monensin-BTG CBDI
Lasalocid Lasalocid-OVA DSC CF131 Lasalocid-BTG CBDI
Nicarbazin GAN-OVA CBDI CF21 Nicarbazin (SAN)-BTG Carbodiimide
Fig. 2 Binding of the five individual polyclonal antisera to the five
different beads of the five-plex
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co-extracted compounds that make them inaccessible for the
antibody binding [37, 38].
Another phenomenon observed was a high background
in feed for the lasalocid assay. Attempts to reduce this
background such as filtration, did not succeed. This back-
ground is consistent, as it was continuously measured over
7 days. A significant part of this background was caused by
the binding of the other antisera to the lasalocid-OVA-
coated beads because the background was lower in the
singleplex assay. Due to these effects, calibration curves
have to be made in matrix-matched extracts of egg or feed
for the correct calculation of sample concentrations.
For eggs, the limits of detection (LODs; mean, 3× stan-
dard deviation) of the assay were below the MRLs for
narasin, diclazuril, nicarbazin and monensin, which was
the desired situation. Even after the reduced sensitivity of
the nicarbazin (DNC) assay in egg extract, it was still
possible to use this assay because of the relatively high
MRL. However, for the lasalocid assay the sensitivity was
too high which may lead in practice to a higher number of
false positive samples (Table 4).
The calibration curves in feed extract showed the dicla-
zuril assay as the only assay with an IC50 close to the ML.
The other four assays had too high sensitivities compared
with the levels set within the EU (Table 4). In a singleplex
assay, an extra dilution can overcome this problem. How-
ever, in this five-plex, the only option is to analyse the
samples at two different dilutions because the diclazuril
assay was not sensitive enough to allow an extra dilution
step.
The optimum extraction method was tested with a blank
feed and egg sample and a blank feed and egg sample spiked
with the different coccidiostats at their MLs or MRLs,
respectively. With all spiked samples, significant inhibitions
were observed which proved the application at the relevant
levels (Fig. 4).
The intra assay variability was determined by measur-
ing one egg or feed sample three times during 3 days and
for the inter assay variability the same samples were
measured ten times on the same day (Table 5). The assay



































Fig. 3 Average calibration
curves of the coccidiostats in
the five-plex (using mixed cali-
bration standards of the five
coccidiostats) in feed (A) and
eggs (B), measured on 2 days,
and buffer (C), measured on
3 days
Table 4 Comparison of assay
sensitivities with the maximum
(residue) levels
Buffer (μg/L) Egg (μg/kg) Feed (μg/kg)
LOD IC50 LOD IC50 ML LOD IC50 ML
Narasin 0.01 0.3 0.01 0.2 2 0.1 2.7 700
Lasalocid 0.03 0.5 0.1 1.8 150 0.2 3 1,250
Diclazuril 0.2 1.9 0.5 6.3 2 0.3 5.3 10
Nicarbazin (DNC) 0.5 9 53 345 100 9 35 500
Monensin 0.01 0.3 0.1 1.2 2 1.5 7.5 1,250
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The assay was tested for its feasibilities in real life.
Preliminary cut-off levels were needed for this qualitative
screening assay and they have been set at 0.5 M(R)L. Three
incurred egg samples which were previously analysed with
LC-MS [14, 39] were assayed with this FCIA. All samples
had concentrations of 0.5 MRL. Two incurred egg samples
contained only one coccidiostat: lacalocid or nicarbazin.
The other incurred egg sample contained three coccidiostats:
salinomycin, monensin and diclazuril. The results obtained
with the three incurred samples in the screening assay were
in accordance with the results obtained with the confirma-
tory method (Table 6). A fourth sample, containing un-
known levels of narasin and nicarbazin was measured with
both methods and in the screening higher inhibitions were
seen than expected. The confirmatory method confirmed the
higher level in this unknown egg sample.
Subsequently six feed samples contaminated with cocci-
diostat additives were analysed. Each feed sample contained
one single coccidiostat at its ML. The results were in accor-
dance with the spiked feed samples except for the cross-
contaminated nicarbazin feed. This sample caused an inhi-
bition in the nicarbazin assay but also unexpected inhibition
in the narasin assay. It later transpired that for the prepara-
tion of the nicarbazin feed the premix Maxiban was used.
This premix contains not only nicarbazin but also narasin
and therefore the assay result was correct. No false positive
nor false negative results were obtained with these real egg
and feed samples.
The ability to store the extracts was tested. It was found
that egg extracts which have been stored at 4 °C for 2 weeks
could be measured without any problems. Feed extracts
were stored in the same way but the standard deviation
between the two measurements increased. The measure-
ments were found to improve if the feed extracts were
shaken for 10 min, followed by a centrifugation step at
2,400×g for 10 min before they were analysed. It could be
concluded that this method gives the opportunity to do the
whole procedure over a single day or to do the extraction on
1 day and analysis of the samples the following day, which
could constitute an advantage for some routine control
laboratories.
During the multiplex assay development the new Lumi-
nex FM3D was introduced and to ensure that the assay
could be transferred between the different platforms, com-
patibility with both instruments was investigated. With the
five-plex coccidiostat assay, calibration curves were mea-
sured with both instruments (Fig. 5) and a very good corre-
lation was observed with the FM3D showing 6 times higher
responses (r ranging from 0.995 to 0.999 for the different
assays). A complete validation for the application in eggs
and feed will be performed taking into account internation-
ally recognised standards such as for example the Commis-
sion Decision 2002/657/EC [40], the guidelines for
validation of a screening methods [41] as well as other
relevant concepts.
Conclusions
In the present study, a bead-based FCIA screening was
developed for the simultaneous detection of six priority
coccidiostats: narasin, salinomycin, lasalocid, diclazuril,
Fig. 4 Average normalised
results (n04) of blank and
spiked egg (left) and feed
samples (right) at the different
MRLs and MLs and in
comparison with the results
obtained with the
corresponding standard solution
Table 5 Precision of the
screening method for the differ-
ent analytes
Egg Feed
Intra-assay CV% Inter-assay CV% Intra-assay CV% Inter-assay CV%
Narasin 1.4 2.3 1.7 0.3
Lasalocid 3.0 3.3 2.5 3.4
Diclazuril 2.3 3.0 1.7 1.3
Nicarbazin (DNC) 1.4 2.4 2.2 2.2
Monensin 1.8 3.4 4.4 2.8
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nicarbazin (DNC) and monensin in egg and feed. The pre-
sented bead-based assay format is very flexible and gives
the opportunity to add other assays at any time, for example
to extend the number of detectable coccidiostats.
Different conjugates were prepared and immobilised on
the beads. These conjugates had a large influences on the
sensitivities and the maximum signals of the assays and
explained the difference in performance between the ELISA
and the FCIA. One assay had the ability to detect two
structurally related coccidiostats (salinomycin and narasin).
When the singleplex assays were combined, the non-
specific binding of antisera with non-associated beads was
too high but could be reduced to acceptable levels by puri-
fying two antisera. The direct coupling of the coccidiostats
on the beads did not have the desired sensitivity and max-
imum binding.
We succeeded to develop a common and simple extrac-
tion procedure for egg and feed samples before analysis by
FCIA. The final LODs for narasin/salinomycin, lasalocid,
diclazuril, nicarbazin (DNC) and monensin in eggs were
0.01, 0.1, 0.5, 53 and 0.1 μg/kg and in feed 0.1, 0.2, 0.3,
9 and 1.5 μg/kg, respectively. This demonstrated that a five-
plex FCIA could detect 6 coccidiostats simultaneously in
eggs and feed at their MRLs and MLs, respectively. Spiked
and incurred egg and feed samples were analysed and no
false positive or false-negative positive results were
obtained. A complete validation will be performed. The
assays were tested for their compatibility with the Luminex
LX100 and FM3D and a very good correlation was ob-
served between both flow cytometers demonstrating ade-
quate transferability between instrumental platforms.
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Table 6 Comparison of the results obtained with the confirmatory and screening methods
Incurred or contaminated
sample
Confirmatory method Screening methoda
MS (μg/kg) Narasin Lasalocid Diclazuril Nicarbazin (DNC) Monensin
Egg 1 Lasalocid (40) √ Non-compliant √ √ √
Egg 2 Nicarbazin (DNC) (60) √ √ √ Non-compliant √
Egg 3 Salinomycin (1.5) Non-compliant √ Non-compliant √ Non-compliant
Monensin (1)
Diclazuril (1)
Egg 4 Narasin (40) Non-compliant √ √ Non-compliant √
Nicarbazin (DNC) (80)
Feed 1 Narasin (580) Non-compliant √ √ √ √
Feed 2 Salinomycin (910) Non-compliant √ √ √ √
Feed 3 Diclazuril (7) √ √ Non-compliant √ √
Feed 4 Nicarbazin (DNC) (570) Non-compliant √ √ Non-compliant √
Feed 5 Monensin (1,000) √ √ √ √ Non-compliant
Feed 6 Lasalocid (1,290) √ Non-compliant √ √ √
Non-compliant0above 0.5 MRL
a √0compliant
Fig. 5 Comparison of the responses (MFIs) obtained with the Lumi-
nex LX100 and the FLEXMAP 3D® system with different calibration
curves of the five-plex
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